HealthcareServices

Revenue of the Angina Market Predicted to Achieve $14.83 Billion by 2030, Driven by 5.3% CAGR

February 19, 2026February 19, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the angina market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Angina Market reach by 2030 starting from 2026 levels?

The angina market has experienced robust expansion in recent years. Projections indicate it will grow from $11.36 billion in 2025 to $12.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. The historical growth in this market can be attributed to the rising prevalence of cardiovascular diseases, the availability of beta blockers and nitrates, the expansion of hospital cardiac care units, increased diagnostic testing, and the growth of cardiology specialty care.

The angina market is set to observe robust growth in the upcoming years, expanding to $14.84 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.3%. This projected growth is attributable to several factors, including the rising demand for individualized cardiovascular treatments, the increasing implementation of minimally invasive cardiac procedures, wider adoption of digital cardiac monitoring technologies, the broadening of preventive cardiology initiatives, and breakthroughs in cardiovascular drug development. Significant trends expected during this forecast period include the increased acceptance of combination drug therapies, a growing reliance on long-acting nitrates, an intensified focus on proactive cardiac care, the expansion of interventional treatment alternatives, and a heightened emphasis on lifestyle and risk management.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Which Drivers Are Influencing Long-Term Growth In The Angina Market?

An increase in cardiovascular disease cases is projected to drive expansion within the angina market in the future. These diseases encompass various heart and blood vessel disorders, including conditions like coronary heart disease, heart failure, and stroke. The rising incidence of cardiovascular diseases is primarily attributable to an aging populace and greater exposure to changeable risk factors like unhealthy eating habits, lack of physical activity, and tobacco consumption. The increasing occurrence of cardiovascular diseases fuels the need for angina treatments, given that these ailments often present with chest discomfort, necessitating medical intervention to alleviate symptoms and avert complications. As an illustration, data from October 2024, provided by the Centers for Disease Control and Prevention, a US-based government agency that monitors public health, indicated that cardiovascular disease deaths rose from 371,506 cases in 2022 to 919,032 deaths in 2023. Consequently, the expanding prevalence of cardiovascular diseases is stimulating the growth of the angina market.

How Is The Angina Market Divided Into Segments?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

How Are New Market Trends Shaping The Landscape Of The Angina Market?

Key companies operating in the angina market are developing novel drugs such as metoprolol tartrate tablets, aiming to deliver more effective and targeted treatments for patients with coronary artery disease (CAD) and related conditions. Metoprolol tartrate tablets are a type of medication commonly prescribed to manage various cardiovascular ailments, including angina (chest pain), hypertension (high blood pressure), and heart failure. For instance, in April 2023, Zydus, an India-based pharmaceutical company, obtained final approval from the United States Food and Drug Administration (US-FDA) to manufacture and market its generic version of Metoprolol Tartrate Tablets USP in strengths of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is used to treat several cardiovascular conditions, including high blood pressure (hypertension) and chest pain (angina), and to improve survival following a heart attack.

Which Leading Companies Dominate The Angina Market Share?

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

How Does The Angina Market Perform Across Major Global Regions?

North America was the largest region in the angina market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Angina Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

Browse Through More Reports Similar to the Global Angina Market 2026, By The Business Research Company

Angio Suites Market Report 2026

https://www.thebusinessresearchcompany.com/report/angio-suites-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Angina Pectoris Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/angina-pectoris-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795